BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease-Reference-Cited by-同舟云学术

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

Published:2019-05-13 Issue:8 Volume:94 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Atiq Ferdows¹^ORCID,Fijnvandraat Karin²³,Galen Karin P. M.⁴,Laros‐Van Gorkom Britta A. P.⁵,Meijer Karina⁶,Meris Joke⁷,Coppens Michiel⁸,Mauser‐Bunschoten Eveline P.⁴,Cnossen Marjon H.⁹,Bom Johanna G.¹⁰¹¹,Eikenboom Jeroen¹²¹³,Leebeek Frank W. G.¹^ORCID,

Affiliation:

1. Department of HematologyErasmus University Medical Center Rotterdam The Netherlands

2. Amsterdam UMCUniversity of Amsterdam, Emma Children's Hospital, Pediatric Hematology Amsterdam The Netherlands

3. Department of Plasma ProteinsSanquin Research Amsterdam The Netherlands

4. Van CreveldkliniekUniversity Medical Center, University Utrecht Utrecht The Netherlands

5. Department of HematologyRadboud University Medical Center Nijmegen The Netherlands

6. Department of HematologyUniversity of Groningen, University Medical Center Groningen Groningen The Netherlands

7. Netherlands Hemophilia Society Leiden The Netherlands

8. Department of Vascular MedicineAmsterdam Cardiovascular Sciences, Amsterdam UMC Amsterdam The Netherlands

9. Department of Pediatric HematologyErasmus University Medical Center‐Sophia Children's Hospital Rotterdam The Netherlands

10. Department of Clinical EpidemiologyLeiden University Medical Center Leiden The Netherlands

11. Jon J van Rood Center for Clinical Transfusion MedicineSanquin Research Leiden The Netherlands

12. Department of Internal Medicine, Division of Thrombosis and HemostasisLeiden University Medical Center Leiden The Netherlands

13. Einthoven Laboratory for Vascular and Regenerative MedicineLeiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25499

Reference6 articles.

1. Obesity, haemostasis and the fibrinolytic system

3. Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease

4. Von Willebrand’s Disease

5. The Genotype-Tissue Expression (GTEx) project

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemoglobin concentration and body mass index are determinants of plasma von Willebrand factor and factor VIII levels;Thrombosis Research;2024-08

2. Total Self-BAT scores associated with choice of heavy menstrual bleeding treatment;2024-03-07

3. Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023;Obesity Pillars;2023-12

4. Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients;Research and Practice in Thrombosis and Haemostasis;2023-02

5. Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical Practice;Clinical and Applied Thrombosis/Hemostasis;2023-01